Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase

被引：45
作者：
Sliman, Faten [1 ]
Blairvacq, Melina [2 ]
Durieu, Emilie [2 ]
Meijer, Laurent [2 ]
Rodrigo, Jordi [1 ]
Desmaele, Didier [1 ]
机构：
[1] Univ Paris Sud, UMR BIOCIS 89076, Fac Pharm, F-92296 Chatenay Malabry, France
[2] Biol Stn, USR3151, Prot Phosphorylat & Human Dis Grp, F-29682 Roscoff, France
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 09期
关键词：
Pim-1; kinase; Inhibitors; Styrylquinolines; Quinoline-2-carboxamides; Molecular docking; HIV-1 REPLICATION INHIBITORS; PROSTATE-CANCER; BINDING MODE; BIOLOGICAL-ACTIVITIES; POTENT; PROTOONCOGENE; INTEGRASE; CELLS; STYRYLQUINOLINES; SPECIFICITY;
D O I：
10.1016/j.bmcl.2010.03.061
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Pim-1 kinase is a cytoplasmic serine/threonine kinase that controls programmed cell death by phosphorylating substrates that regulate both apotosis and cellular metabolism. A series of 2-styrylquinolines and quinoline-2-carboxamides has been identified as potent inhibitors of the Pim-1 kinase. The 8-hydroxyquinoline 7-carboxylic acid moiety appeared to be a crucial pharmacophore for activity. Molecular modeling indicated that interaction of this scaffold with Asp186 and Lys67 residues within the ATP-binding pocket might be responsible for the kinase inhibitory potency. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2801 / 2805
页数：5
相关论文
共 47 条
[11]   An Improved Screening Model To Identify Inhibitors Targeting Zinc-Enhanced Amyloid Aggregation [J].
Chang, Pei-Teh ;
Kung, Fan-Lu ;
Talekar, Rahul Subhash ;
Chen, Chien-Shu ;
Lai, Shin-Yu ;
Lee, Hsueh-Yun ;
Chern, Ji-Wang .
ANALYTICAL CHEMISTRY, 2009, 81 (16) :6944-6951
[12]   Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells [J].
Chen, Lisa S. ;
Redkar, Sanjeev ;
Bearss, David ;
Wierda, William G. ;
Gandhi, Varsha .
BLOOD, 2009, 114 (19) :4150-4157
[13]   Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase [J].
Cheney, I. Wayne ;
Yan, Shunqi ;
Appleby, Todd ;
Walker, Hell ;
Vo, Todd ;
Yao, Nanhua ;
Hamatake, Robert ;
Hong, Zhi ;
Wu, Jim Z. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (06) :1679-1683
[14]   Ruthenium half-sandwich complexes bound to protein kinase Pim-1 [J].
Debreczeni, JÉ ;
Bullock, AN ;
Atilla, GE ;
Williams, DS ;
Bregman, H ;
Knapp, S ;
Meggers, E .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (10) :1580-1585
[15]   Delineation of prognostic biomarkers in prostate cancer [J].
Dhanasekaran, SM ;
Barrette, TR ;
Ghosh, D ;
Shah, R ;
Varambally, S ;
Kurachi, K ;
Pienta, KJ ;
Rubin, MA ;
Chinnaiyan, AM .
NATURE, 2001, 412 (6849) :822-826
[16]   Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase [J].
Grey, Ron ;
Pierce, Albert C. ;
Bemis, Guy W. ;
Jacobs, Marc D. ;
Moody, Cameron Stuver ;
Jajoo, Rahul ;
Mohal, Narinder ;
Green, Jeremy .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (11) :3019-3022
[17]   Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase [J].
Holder, Sheldon ;
Lilly, Michael ;
Brown, Milton L. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (19) :6463-6473
[18]   Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase [J].
Holder, Sheldon ;
Zemskova, Marina ;
Zhang, Chao ;
Tabrizizad, Maryam ;
Bremer, Ryan ;
Neidigh, Jonathan W. ;
Lilly, Michael B. .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (01) :163-172
[19]   Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002 [J].
Jacobs, MD ;
Black, J ;
Futer, O ;
Swenson, L ;
Hare, B ;
Fleming, M ;
Saxena, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (14) :13728-13734
[20]   Development and validation of a genetic algorithm for flexible docking [J].
Jones, G ;
Willett, P ;
Glen, RC ;
Leach, AR ;
Taylor, R .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) :727-748
12345